Skip to main content

Find Clinical Trials

Home
Conditions
Inhalation anthrax

Clinical trial condition

Inhalation anthrax

Explore clinical trials studying Inhalation anthrax. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Inhalation anthrax trial results

Not Yet Recruiting

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

NCT03569553

Conditions: Anthrax, Bacillaceae Infections, Bacterial Infections, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

NCT07268612

Conditions: Anthrax, Bacillaceae Infections, Bacterial Infections, +6 more
Locations: Not specified

View Trial Details

Completed

Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum

NCT00448253

Conditions: Inhalation anthrax, Symptoms of Inhalational Anthrax
Locations: MDS Pharma Services Lincoln, Nebraska, United States

View Trial Details

Completed

Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers

NCT01932242

Conditions: Anthrax, Bacillaceae Infections, Bacterial Infections, +5 more
Locations: Quintiles Overland Park, Kansas, United States

DaVita Minneapolis, Minnesota, United States

View Trial Details

Completed

Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers

NCT01932437

Conditions: Inhalation anthrax, Inhalational Anthrax
Locations: Covance Clinical Research Unit Inc. Dallas, Texas, United States

View Trial Details

Completed

Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers

NCT01952444

Conditions: Inhalation anthrax, Inhalational Anthrax
Locations: Quintiles Overland Park, Kansas, United States

View Trial Details

Completed

Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers

NCT01929226

Conditions: Anthrax, Bacillaceae Infections, Bacterial Infections, +5 more
Locations: Covance Clinical Research Inc. Dallas, Texas, United States

View Trial Details